Gerresheimer Ag logo

Gerresheimer Ag(OTC) GRRMF

Market Cap$1.00BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2009)+35%
5 Year-71%
1 Year-43%
1 Month-7%
$29.05
+0.00%
+0.00Today
Gerresheimer Ag last closing stock price
MetricPriceDate
Last closeUSD 29.052026-09-22
Gerresheimer Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-9.78%USD 32.202026-08-28
1 month-6.71%USD 31.142026-08-12
3 month-9.5%USD 32.102026-06-01
Year to date-21.12%USD 36.832025-11-12
1 year-43.49%USD 51.412025-09-05
3 year-77.34%USD 128.182023-09-07
5 year-70.58%USD 98.732021-09-14
Since inception+34.6%USD 21.582009-02-12

Gerresheimer Ag Financials at a Glance

Market Cap

$1.00BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€2.28B

Net Income (TTM)

-€402.11M

EPS (TTM)

-$13.57

P/E Ratio

-2.14

Dividend

$0.00

Beta (Volatility)

-0.16 (Low)

Price

$29.05

Volume

690

Open

$29.05

Previous Close

$29.05

Daily Range

$29.05 - $29.05

52-Week Range

$19.17 - $36.83

Estimated Earnings Date

Nov 4, 2026

GRRMF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Gerresheimer Ag

Gerresheimer AG is a leading manufacturer of packaging solutions and drug delivery devices, serving the pharmaceutical, biotechnology, and medical technology sectors. Established in 1864 and headquartered in Düsseldorf, Germany, the company operates through three primary divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies.

Products and Services
  • Comprehensive drug delivery systems, including inhalers and prefillable syringes
  • Essential glass packaging for pharmaceuticals and cosmetics
  • Innovative smart drug delivery systems, such as micro-pumps
Growth Outlook
  • Revenue increased to €639 million in Q4 2025, showing strong demand
  • Operating income improved to €7.4 million in Q3 2025, indicating operational efficiency
  • Investment in R&D reached €71 million in Q4 2025, supporting future innovations
Financial Highlights
  • Trailing twelve months (TTM) revenue of €2.4 billion, reflecting steady growth
  • Net income margin of -0.48% in Q4 2025, highlighting challenges in profitability
  • Cash flow from operations of €89.7 million in Q4 2025, demonstrating liquidity strength
Gerresheimer AG has established itself as a key player in the healthcare packaging industry, with a diverse product portfolio that caters to various sectors. The company's focus on innovation, particularly in smart drug delivery systems, positions it well for future growth. Recent financial performance indicates a solid revenue trajectory, although challenges in profitability remain. The investment in research and development underscores a commitment to advancing technology and meeting evolving market needs. Overall, Gerresheimer AG presents a compelling opportunity for investors interested in the healthcare sector.
AI Generated • Sep 24, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

13,301

CEO

Uwe Ferdinand Röhrhoff

Website

www.gerresheimer.com

Headquarters

Düsseldorf, NW 40468, DE

GRRMF Financials

Key Financial Metrics (TTM)

Gross Margin

15.28%

Operating Margin

-11.90%

Net Income Margin

-17.60%

Return on Equity

-32.84%

Return on Capital

-6.19%

Return on Assets

-9.21%

Earnings Yield

-46.73%

Dividend Yield

0.00%

Payout Ratio

-0.59%

Stock Overview

Market Cap

$1.00BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

34.54M

Volume

690

Avg. Volume

38.369

Financials (TTM)

Gross Profit

€471.55M

Operating Income

-€271.49M

EBITDA

€362.45M

Operating Cash Flow

€261.97M

Capital Expenditure

-€263.26M

Free Cash Flow

€368.86M

Cash & ST Invst.

€167.97M

Total Debt

€2.21B

Gerresheimer Ag Performance Analysis

Gerresheimer Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-11-30EUR 1,920,956,7947.8%
20232023-11-30EUR 2,146,348,09511.7%
20242024-11-30EUR 2,161,363,6920.7%
20252025-11-30EUR 2,593,422,24120.0%
Gerresheimer Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-05-3115.5%
Q32025-08-31-6.7%
Q42025-11-3014.1%
Q12026-02-28-24.6%
Gerresheimer Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-11-30EUR 3.241.9%
20232023-11-30EUR 3.7616.1%
20242024-11-30EUR 2.59-31.2%
20252025-11-30EUR -10.36N/A
Gerresheimer Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-05-31194.2%
Q32025-08-31-175.5%
Q42025-11-30-2300.0%
Q12026-02-2867.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

€482.13M

-7.3%

Gross Profit

€50.01M

-60.5%

Gross Margin

10.37%

N/A

Market Cap

$1.00BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$74.17K

N/A

Employees

13,528

N/A

Net Income

-€99.81M

-454.1%

EBITDA

€9.70M

-88.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

€167.97M

-8.6%

Total Debt

€2.21B

-3.2%

Accounts Receivable

€255.02M

-24.0%

Inventory

€440.14M

-14.8%

Long Term Debt

€1.59B

+67.7%

Short Term Debt

€619.53M

-54.8%

Return on Assets

-9.21%

N/A

Return on Invested Capital

-9.27%

N/A

Free Cash Flow

-€40.62M

+92.0%

Operating Cash Flow

€24.66M

+188.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,709.28-0.01%
^DJIDJI
$51,466.30-0.00%
^IXICNASDAQ
$26,684.28-0.02%
BTCBitcoin
$81,564.00-0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$221.30-3.16%
BACBank of America
$51.39-4.76%
CRWVCoreWeave
$65.78-15.46%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$110.54-13.35%

Questions About GRRMF

What is the current price of Gerresheimer Ag?

Gerresheimer Ag is trading at $29.05 per share.

What is the 52-week range for Gerresheimer Ag?

Over the past 52 weeks, Gerresheimer Ag has traded between $19.17 and $36.83.

How much debt does Gerresheimer Ag have?

As of the most recent reporting period, Gerresheimer Ag reported total debt of €2.60B.

How much cash does Gerresheimer Ag have on hand?

Gerresheimer Ag reported €197.90M in cash and cash equivalents in its most recent financial results.

What is Gerresheimer Ag’s dividend yield?

Gerresheimer Ag does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services